EPRT's focus on mid-market, service-oriented tenants and sale-leaseback deals enables superior returns and diversification.

At today’s $52B EV, CoreWeave trades at 22–29x forward EV/EBITDA, reflecting strong revenue visibility but limited multiple ...

IO Biotech Inc. research and ratings by Barron's. View IOBT revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory ...

Hyperion Biosystems and Colorcon have announced a licensing agreement aimed at revolutionizing the fight against counterfeit ...

The truth is clear: Animal models aren’t just helpful; they’re irreplaceable. They remain central to understanding the ...

BetterLife Pharma Inc. research and ratings by Barron's. View NPAU revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...